DIAGNOLOGIX, LLC

San Diego, CA · Biotech · Private

Microbubble-based platform for high-purity regulatory T cell isolation and manufacturing at scale

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · diagnologix.com

Sector: Biotech
Headquarters: San Diego, CA
Total capital: $8.2M

Federal grants: $5.9M; 8 awards · 2014–2023; Rank in peer group#6 of 18
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $2.4M; 2 awards · Health and Human S; Rank in Biotech#128 of 4373
Granted patents: 3; 6 pending · first 2019; Rank in peer group#3 of 18

Capital timeline

Latest events

Aug 2023Federal grantHealth and Human S · Phase II · Toward GMP production of antigen specific regulatory T cells$900K
Sep 2022Federal grantHealth and Human S · Phase II · Toward GMP production of antigen specific regulatory T cells$2M
Sep 2021Federal grantHealth and Human S · Phase II · Toward GMP production of antigen specific regulatory T cells$300K
Sep 2019Federal contractHealth and Human S · Topic 360: A Simple End-to-end System For Serial Cell Sorting And Manipulation Using A Single Container- Moonshot$2M
Jul 2018Federal grantHealth and Human S · Phase II · An Innovative System For Cord Blood Stem Cell Isolation$750K
Sep 2017Federal contractHealth and Human S · Igf::ot::igf SBIR 360: A Simple End-to-end System For Serial Cell Sorting And Manipulation Using A Single Container$350K
Aug 2017Federal grantHealth and Human S · Phase II · An Innovative System For Cord Blood Stem Cell Isolation$750K

Show 3 earlier federal awards

Jun 2016Federal grantHealth and Human S · Phase II · Buoyancy based bioseparations$500K
Apr 2015Federal grantHealth and Human S · Phase II · Buoyancy based bioseparations$500K
Nov 2014Federal grantHealth and Human S · Phase I · An Innovative system for cord blood stem cell isolation$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 18 peers

Line = median

Biotech · Device

Federal grants#6 · top 33%
Granted patents#3 · top 17%
Linked publications#3 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 9

Oct 2, 2025PendingClosed Automated System And Method For Multiplex Cell ProcessingUSPTOApplication 18618922
Nov 26, 2024GrantedMethod For Activating And Expanding Isolated T CellsUSPTOUS 12,152,250
May 19, 2022PendingArtificial Virus Presenting CellsUSPTOApplication 17550958

Show all 9 patent records

Closed Automated System And Method For Multiplex Cell ProcessingOct 2, 2025 · Application 18618922Pending
Method For Activating And Expanding Isolated T CellsNov 26, 2024 · US 12,152,250Granted
Artificial Virus Presenting CellsMay 19, 2022 · Application 17550958Pending
Buoyancy Enabled Separation Method And SystemNov 19, 2019 · US 10,479,976Granted
System And Apparatus For Isolating Or Enriching Agents Using FloatationMay 28, 2019 · US 10,302,536Granted
Artificial Virus Presenting CellsApplication 63113817Pending
Artificial Virus Presenting CellsApplication PCTUS2021058634Pending
Closed Automated System And Method For Multiplex Cell ProcessingApplication PCTUS2024021769Pending
Buoyancy Enabled Separation Method And SystemApplication PCTUS2017066525Pending

Recent research by its founders

Abstract 3704: Long-term <i>ex vivo</i> expansion of functional CAR-T cells using the biomimetic AeroCyte-based artificial antigen-presenting cell platform20260 cites
Study on the Fire Resistance of Castellated Composite Beams with Semi-Rigid Restraints20251 cites
TRIM37 exacerbates cerebral ischemic injury by regulating the PPARγ/NF-κB pathway20242 cites

PROTEIOS TECHNOLOGY, INC.Similar federal contract value in Biotech · $2.5M in contracts
STEMINA BIOMARKER DISCOVERY, INCSimilar federal contract value in Biotech · $2.5M in contracts
Vetigenics LLCSimilar federal contract value in Biotech · $2.4M in contracts
CHROMATAN INCSimilar federal contract value in Biotech · $2.3M in contracts
WILSON WOLF MANUFACTURING CORPORATIONSimilar federal contract value in Biotech · $2.3M in contracts
MODULATION THERAPEUTICS, INC.Similar federal contract value in Biotech · $2.3M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.